KATIE SIMON: Open Payments
NPI 1790204592 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 30 payments from 12 companies in 2025. Trend: 2023 $160 · 2024 $384 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 6 | $187 |
| ABBVIE INC. | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $58 |
| Indivior Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Orexo US, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
Products named: BRIXADI, REXULTI, Auvelity, VRAYLAR, MOUNJARO, SUBLOCADE, TRELEGY ELLIPTA, Zubsolv.
Industry payments across MI — which companies pay providers there.
